About ZHESHANG
Overview
ZHESHANG is a financial broker headquartered in Hangzhou, China, with its official domain at cnzsqh.com. According to public records, the company was founded on August 16, 2018, and operates under a Derivatives Trading License (AGN) from the China Financial Futures Exchange (CFFEX). The broker describes itself as a regulated entity that strictly complies with legal requirements, though independent information about its operations is limited.
Regulation
ZHESHANG holds a regulatory license from CFFEX, China's sole exchange for financial futures. The license status is listed as 'Regulated' in China, indicating compliance with local derivative trading laws. However, this regulation applies only to derivatives products, and the broker does not appear to hold additional licenses for retail forex or CFD trading outside of China.
Trading Instruments
The broker’s official description mentions that it offers five types of trading instruments, which likely include futures and other derivatives traded through CFFEX. Beyond this general claim, no specific instrument list is publicly available from the data we have.
Trading Platforms
ZHESHANG states that it supports trading through multiple platforms, but the names and details of these platforms are not specified in the available records. Traders would need to contact the broker directly for platform information.
Account Types
No account types have been disclosed in the known facts. Given the limited public information, prospective clients should inquire directly about account tiers, minimum deposits, and spreads.
Funding
Funding methods and withdrawal processes are not documented in the available data. As a Chinese-regulated entity, funding options may be localized to Chinese banks and payment systems.
Conclusion
ZHESHANG appears to be a niche broker focused on the Chinese derivatives market under CFFEX oversight. Due to the scarcity of independent reviews and publicly available operational details, traders should exercise caution and conduct further due diligence before engaging.
Overview compiled by FXCanary from regulatory records and public data. full ZHESHANG review